Bg pattern

ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Abiprost 0.3 mg/ml eye drops solution in single-dose container

bimatoprost

Read the package leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet

  1. What is Abiprost and what is it used for
  2. What you need to know before you use Abiprost
  3. How to use Abiprost
  4. Possible side effects
  5. Storage of Abiprost
  6. Contents of the pack and further information

1. What is Abiprost and what is it used for

Abiprost 0.3 mg/ml single-dose is a medicine for glaucoma. Abiprost belongs to a group of medicines called prostamides.

Abiprost 0.3 mg/ml eye drops single-dose is used to reduce high pressure in the eye. This medicine can be used alone or with other eye drops called beta-blockers that also reduce pressure.

The eye contains a clear, watery liquid that keeps the inside of the eye healthy. This liquid is constantly drained out of the eye and new liquid is produced to replace it. If the liquid does not drain quickly enough, the pressure inside the eye increases. This medicine works by increasing the drainage of the liquid. This reduces the pressure inside the eye. If this pressure is not reduced, it could lead to a disease called glaucoma and damage your vision.

This medicine does not contain preservatives

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Abiprost

Do not use this medicine:

  • If you are allergic to bimatoprost or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions:

Consult your doctor or pharmacist before starting to use Abiprost.

Talk to your doctor or pharmacist if:

  • you have any respiratory problems.
  • you have liver or kidney problems.
  • you have had cataract surgery in the past.
  • you have low blood pressure or a slow heart rate
  • you have had a viral infection or inflammation of the eye

During treatment, Abiprost may cause loss of fat around the eye, which can cause deepening of the eyelid sulcus, sinking of the eyes (enophthalmos), drooping of the eyelids (ptosis), stretching of the skin around the eye (involution of dermatocalasis), and the white part of the eye becomes more visible (inferior scleral exposure). The changes are usually mild, but if they become more pronounced, they can affect your field of vision. The changes may disappear if you stop using Abiprost. Abiprost may also cause darkening and growth of the eyelashes, as well as darkening of the skin around the eyelid. The color of the iris may darken. These changes may be permanent and more noticeable if only one eye is being treated.

Children and adolescents

Abiprost has not been studied in children under 18 years of age and therefore should not be used in patients under 18 years of age.

Other medicines and Abiprost

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Abiprost may pass into breast milk, so you should not use it if you are breastfeeding.

Driving and using machines

After instilling Abiprost, blurred vision may occur for a short time. Do not drive or use machines until you can see clearly.

3. How to use Abiprost

Follow exactly the instructions for administration of this medicine given by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.

The recommended dose is one drop in each eye that needs treatment, once a day, in the evening. Abiprost should only be used in the eye.

If you use Abiprost with another eye medicine, wait at least 5 minutes between using Abiprost and the other eye medicine.

Do not use the medicine more than once a day, as this may reduce the effectiveness of the treatment.

Wash your hands before using it. Make sure the single-dose container is intact before using this medicine. The solution should be used immediately after opening the container. To avoid contamination, do not let the tip of the single-dose container touch the eye or any other surface.

Hands holding an intrauterine device at different stages of insertion and manipulation

  1. Take a single-dose container and hold it in an upright position (with the cap facing up) and twist the cap until it comes off.
  2. Gently pull the lower eyelid down to form a pouch. Invert the single-dose container and squeeze until one drop falls into the eye or eyes to be treated.
  3. Discard the single-dose container after use, even if there is still solution inside.

Wipe away any excess that runs down your cheek.

If you wear contact lenses, you should remove them before using this medicine. Wait 15 minutes after using the drops before putting your lenses back in.

If you use more Abiprost than you should

If you use more of this medicine than you should, it is unlikely to cause you any serious harm. Apply the next dose at the usual time. If you are concerned, talk to your doctor or pharmacist.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to use Abiprost

If you forget to apply this medicine, use one drop as soon as you remember and then go back to your usual routine. Do not apply a double dose to make up for the forgotten dose.

If you stop using Abiprost

Abiprost should be used every day for it to work well. If you stop using Abiprost, the pressure in the eye may increase, so consult your doctor before stopping treatment.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Very common side effects

These may affect more than 1 in 10 people

Affecting the eye

  • Mild redness (up to 24% of people)
  • Loss of fat in the eye area that can cause deepening of the eyelid sulcus, sinking of the eyes (enophthalmos), drooping of the eyelids (ptosis), stretching of the skin around the eye (involution of dermatocalasis), and the white part of the eye becomes more visible (inferior scleral exposure).
Common side effects

These may affect between 1 and 9 people in 100Affecting the eye

  • Small erosions on the surface of the eye, with or without inflammation
  • Irritation
  • Itching in the eyes
  • Pain
  • Dryness
  • Feeling of having something in the eye
  • Longer eyelashes
  • Darker skin around the eye
  • Red eyelids
Uncommon side effects

These may affect between 1 and 9 people in 1,000

Affecting the eye

  • Tired eyes
  • Sensitivity to light
  • Darker iris
  • Inflamed and itchy eyelids
  • Watery eyes
  • Inflammation of the clear layer that covers the surface of the eye
  • Blurred vision

Affecting the body

  • Headaches
  • Growth of hair around the eye

Side effects of unknown frequency

Affecting the body

  • Asthma
  • Worsening of asthma
  • Worsening of chronic obstructive pulmonary disease (COPD)
  • Breathing difficulties
  • Symptoms of allergic reaction (inflammation, redness of the eye, and skin rash).
  • Dizziness
  • High blood pressure
  • Discoloration of the skin (periorbital)

Affecting the eye

  • Sticky eyes
  • Eye discomfort

In addition to the side effects mentioned above, the following side effects have been observed with the multidose formulation with preservative of bimatoprost and may occur in patients using Abiprost 0.3 mg/ml single-dose:

  • Burning sensation in the eye
  • Allergic reaction in the eye
  • Inflammation of the eyelid
  • Difficulty seeing clearly
  • Worsening of vision
  • Darker eyelashes
  • Retinal hemorrhage
  • Inflammation inside the eye
  • Cystoid macular edema (inflammation of the retina inside the eye that leads to worsening of vision)
  • Inflammation of the iris
  • Lid twitching
  • The eyelid has contracted and separated from the surface of the eye
  • Nausea
  • Redness of the skin around the eye
  • Weakness
  • Increased levels of liver function tests in the blood

Other side effects reported with phosphate-containing eye drops:

This medicine contains 0.38 mg of phosphate in each single-dose.

If you have severe damage to the clear layer on the front of the eye (cornea), treatment with phosphates, in very rare cases, may cause blurred vision due to calcium deposits.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Abiprost

Keep this medicine out of the sight and reach of children.

This medicine is for single use and does not contain preservatives. Do not store the unused solution.

Do not use this medicine after the expiry date which is stated on the single-dose container and on the aluminum pouch after the expiry date (EXP):. The expiry date is the last day of the month shown.

This medicine does not require any special storage temperature. However, once the aluminum pouch is opened, it should be used within 30 days.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of Abiprost 0.3 mg/ml eye drops solution in single-dose container

  • The active substance is bimatoprost. One ml of solution contains 0.3 mg of bimatoprost.
  • The other ingredients are sodium chloride, anhydrous sodium hydrogen phosphate, citric acid monohydrate, and water for injections. Small amounts of hydrochloric acid or sodium hydroxide may be added to maintain the normal level of acidity (pH levels).

Appearance of the product and pack contents

Abiprost 0.3 mg/ml eye drops solution in single-dose container is a clear and transparent solution supplied in plastic single-dose containers, each containing 0.4 ml of solution.

Each 5 single-dose containers are packaged in an aluminum pouch.

Each carton contains 30 single-dose containers.

Marketing authorisation holder and manufacturer

Marketing authorisation holder

Tiedra Farmacéutica, S.L.

C/ Colón, 7

30510 Yecla

Murcia

Spain

Manufacturer

Laboratorios Lesvi, S.L.

Avda. Barcelona, 69

08970 Sant Joan Despí

Barcelona

Spain

Date of last revision of this leaflet: February 2022

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)

Online doctors for ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS

Discuss questions about ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
The active ingredient in ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is bimatoprost. This information helps identify medicines with the same composition but different brand names.
Who manufactures ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is manufactured by Tiedra Farmaceutica S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ABIPROST 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
Other medicines with the same active substance (bimatoprost) include AMIRIOX 0.3 mg/ml EYE DROPS SOLUTION, BIMATOPROST STADA 0.3 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS, BIMEOX 0.3 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media